• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SYNTHES GMBH UNK - SCREWS: MATRIXMIDFACE; SCREW, FIXATION, INTRAOSSEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SYNTHES GMBH UNK - SCREWS: MATRIXMIDFACE; SCREW, FIXATION, INTRAOSSEOUS Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Fluid Discharge (2686)
Event Date 01/01/2020
Event Type  Injury  
Manufacturer Narrative
Event date: exact date of event is unknown; event occurred sometime between the original procedure on (b)(6) 2020 and wound secretion discovery on (b)(6) 2020.This report is for an unknown mandible screw/unknown lot.Part and lot number are unknown; udi number is unknown.Complainant part is not expected to be returned for manufacturer review/investigation.Without a lot number the device history records review could not be completed.Product was not returned.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event Description
Device report from synthes (b)(4) reports an event as follows: it was reported that the patient underwent the surgery of internal fixation of a mandibular fracture on (b)(6) 2020.On (b)(6) 2020, the patient was admitted to hospital.Examination of the lower vestibular sulcus showed incision scar, good jaw relationship and strong chewing.A sinus was formed in the submandibular area.A small amount of wound secretion was observed in the submandibular area.On (b)(6) 2020, the patient underwent a maxillofacial bone internal fixation removal surgery under general anesthesia.After removing the plate, the patient's wound secretion was improved.No additional information can be provided.This report is for an unknown mandible screw.This is report 2 of 2 for (b)(4).
 
Manufacturer Narrative
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If the information is unknown, not available or does not apply, the section/field of the form is left blank.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK - SCREWS: MATRIXMIDFACE
Type of Device
SCREW, FIXATION, INTRAOSSEOUS
Manufacturer (Section D)
SYNTHES GMBH
eimattstrasse 3
oberdorf 4436
SZ  4436
MDR Report Key12452903
MDR Text Key270799588
Report Number8030965-2021-07629
Device Sequence Number1
Product Code DZL
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 08/13/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 08/13/2021
Initial Date FDA Received09/10/2021
Supplement Dates Manufacturer Received09/23/2021
Supplement Dates FDA Received10/21/2021
Patient Sequence Number1
Treatment
ADAPTPL 20HO T0.7 TI; ADAPTPL 20HO T0.7 TI
Patient Outcome(s) Required Intervention;
Patient Age11 YR
-
-